Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children - Wikidata - awgldk - TriplyDB

Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children

Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children

http://www.wikidata.org/entity/Q22241502

about

ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder.Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.European guidelines on managing adverse effects of medication for ADHD.Methylphenidate-induced mania-like symptoms.The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study.Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes Complex diagnostic and treatment issues in psychotic symptoms associated with narcolepsy Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.Beyond the first episode: candidate factors for a risk prediction model of schizophrenia.The use of lisdexamfetamine dimesylate for the treatment of ADHD.Enhancing ADHD medication adherence: challenges and opportunities Managing the risks of ADHD treatments.Use of Stimulants in Bipolar Disorder.The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.Associations of attention-deficit/hyperactivity and other childhood disorders with psychotic experiences and disorders in adolescence.Reporting a Case of Injecting Methylphenidate (Ritalin) Tablets, Intensified Symptoms of Schizoph-renia or Induce Separate Mental Disorder?Manic Symptoms Due to Methylphenidate Use in an Adolescent with Traumatic Brain Injury.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UK.Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere.Differentiating between comorbidity and symptom overlap in ADHD and early onset bipolar disorder.

P2860

Q22241496-0316A95D-D3FC-4DCD-BD5C-387C9E9F3BC8 Q28260681-9D44AC05-094D-492F-B937-DF4CBBE8C9A6 Q28282770-CB342095-CEA2-4E0A-88F5-2EAA02DD96B1 Q30468347-F96ABB33-515E-4566-9A81-975B2C0959CD Q34182040-A16D21ED-3472-41FF-85EF-F55DF0FD2D73 Q34362939-D319C49F-D418-40D8-B557-8CC16689D545 Q34448884-D13F06B2-D46F-427F-A835-C7F24EC3179C Q34628080-432BD060-1F8C-4AA6-B9E8-313D48D92B9C Q34673021-87BD30E8-AB78-4F26-AB7C-BFF6DD43C333 Q36983429-A81B25E0-0112-4A78-840D-C81FBC652319 Q37564867-7D737B6F-DB30-4441-8ECF-0D113C1F613C Q37590701-9A18DFA3-F089-49EE-9838-4EA395138E0C Q37648289-42DEAAB5-B149-4F57-A9A4-0DE8AFF4EC22 Q37760933-20A483F3-F089-4256-9DD6-60A3395FF7D7 Q37975550-28ECDDFD-A82D-4476-BE9A-18A4B5937BFB Q38109853-575AAF17-8A1A-45A7-8F60-C67ACA752054 Q38241131-61DF863B-FBA6-4FED-9902-695AC3D57FE2 Q39112970-32F564E7-B708-4C2E-8E1C-82D2D0A921E4 Q39433708-C92820E1-9565-4593-859F-FE83E79656DB Q40583357-FF08BA60-F9ED-45DF-8CBD-35ED49DE78CD Q41895882-68A0F9D9-FC72-459D-944F-C007B345D0C7 Q42371921-56BAC430-A23D-44F3-BD06-72062AD7E61C Q47677209-B792E729-B368-4690-9961-5010275CFEA4 Q48316302-A127E584-BAE6-46FD-AFF9-731F611C0799 Q50440637-B768D1C4-B431-4D4F-9F6A-77104A1BE422 Q50642240-98D5D910-B86B-4215-A42C-DEFC6360E21D

P2860

Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children

http://www.wikidata.org/entity/Q22241502

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@ast

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@en

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@en-gb

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@nl

type

label

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@ast

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@en

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@en-gb

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@nl

altLabel

Hallucinations and other psych ...... ity disorder drugs in children

@en

prefLabel

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@ast

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@en

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@en-gb

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@nl

P1433

Q22241502-5CCDA8BB-E785-4EB0-96F1-7EB3330101B2

P1476

Q22241502-A21791C9-211F-4C7E-B45F-F5F7472E016B

P2093

Q22241502-1A0209DE-D4D0-400C-AAB5-46C5EFFBDFCB

Q22241502-31E1BD01-D79E-4739-8AE5-D016D0A1B83C

Q22241502-46276C0E-26FC-4939-903C-485E157F2D26

Q22241502-5E912490-AC9E-4517-AD3D-3E044EBCAA5C

Q22241502-B12CE4E3-CAF5-4355-B139-9BB6D2ED9B74

P304

Q22241502-0D30C4FC-1CCA-4E27-8F19-20FA5B5F6B03

P31

Q22241502-54264D71-0569-4F75-8F53-FE739D1256C4

P3181

Q22241502-28C248F9-5239-4883-AF1D-E03F1CF9D335

P356

Q22241502-D052483B-1F5D-4CDB-B1DF-41B06C52BF76

P407

Q22241502-3F6FEBFC-6E1C-41B4-92C5-E772690B9991

P433

Q22241502-E41C346E-C7B7-4CD1-BA78-56009A1B71DE

P478

Q22241502-9600E446-9A31-4C1E-AF9A-FD6213F83DC4

P577

Q22241502-FBD063C4-98CC-439E-8DE6-22ACB7EDBD73

P5875

Q22241502-A7D92F7B-5E6F-4D6A-B97C-BDCC0CBC6D51

P698

Q22241502-CF5E902B-75A0-4F6F-B4F5-C2438C6B7AC3

P921

Q22241502-193A4C78-2A14-4A17-9E75-B21B83E2A313

Q22241502-4211112E-6229-412D-AA7B-F45F18DF102F

Q22241502-8F6C3C49-9B67-4848-BA52-FBA890A3FAA3

Q22241502-F6D9F9A7-E68A-4058-A5FC-5782B9FAF69E

P3181

P356

P1433

P1476

Hallucinations and Other Psych ...... ity Disorder Drugs in Children

@en

P2093

A. D. Mosholder

http://www.w3.org/2001/XMLSchema#string

K. Gelperin

http://www.w3.org/2001/XMLSchema#string

K. Phelan

http://www.w3.org/2001/XMLSchema#string

R. Johann-Liang

http://www.w3.org/2001/XMLSchema#string

T. A. Hammad

http://www.w3.org/2001/XMLSchema#string

P304

611-616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4381836

http://www.w3.org/2001/XMLSchema#string

P356

10.1542/PEDS.2008-0185

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23950768

http://www.w3.org/2001/XMLSchema#string

P698

19171629

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder